Internal Server Error

About Shanghai Creation Investment

Shanghai Creation Investment is a venture capital firm founded in 2006. It is primarily based out of Shanghai, China. As of Jul 2021, Shanghai Creation Investment has invested in 25 companies. It primarily invests in Series B round in China based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series A round of Rui Bai Overall, Shanghai Creation Investment portfolio has seen 4 IPOs and 1 acquisition including key companies like Akeso, Cleveland HeartLab and Utilight. A lot of funds co-invest with Shanghai Creation Investment, with names like Zhongguancun Development Group sharing a substantial percentage of its portfolio. Shanghai Creation Investment has team of 8 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Series B
Portfolio Acquisitions
Portfolio Soonicorns

Shanghai Creation Investment's List of Top Investments

Shanghai Creation Investment has a portfolio of 25 companies. Their most notable investments are in Cygnus Bio and Shenyang Shenda Endoscope.Their portfolio spans across China, Israel and United States. They have invested in Life Sciences, High Tech, Enterprise Applications and 9 other sectors, across stages such as Series A, Series B stages. Here is the list of top investments by Shanghai Creation Investment:
Developer of antibody drug conjugates for the treatment of broad spectrum diseases. The company utilizes proprietary Tetrabody technology to develop pipeline of products for cancer, autoimmune disease, inflammation, metabolic disease, and other therapeutic fields.

Key facts about Akeso

Surgical Theater enhances surgical precision using XR technology. It provides immersive XR experiences throughout a patient's surgical journey, from planning and rehearsal to the procedure itself. The platform offers tools for surgical planning, patient engagement, and improved OR visualization. These tools utilize patient-specific XR reconstructions to help surgeons visualize complex anatomy and potential risks, leading to better surgical outcomes. The technology also helps patients understand their procedures more effectively. This approach aims to improve surgical precision and patient outcomes.

Key facts about Surgical Theater

Manufacturer of solar modules, energy storage systems, and EPC services. It offers a range of solar modules, including bifacial half-cell and single-glass options. The company also provides energy storage solutions and complete engineering, procurement, and construction (EPC) services for solar power projects. These services encompass the entire project lifecycle, from development to operation. Integrated rooftop systems are also part of their offerings.

Key facts about ZNShine PV-Tech

  • Founded Year: 1998
  • Location: Changzhou (China)
  • Stage: Funding Raised
  • Employee Count: 191 as on Aug 31, 2026
  • Investors: Shanghai Creation Investment
  • Highlight: Editors' Pick
Innovative cardiovascular biomarker testing for risk identification and disease prevention. They offer advanced biomarker testing services, including inflammatory markers, to aid clinicians in identifying cardiovascular risk and reducing events. The company focuses on innovation through research and development, partnering with institutions to bring unique biomarker technologies to market. They are committed to education, providing resources and events for healthcare providers and patients to understand cardiovascular risk. The company operates a CAP-accredited and CLIA-certified clinical reference laboratory, offering a pipeline of novel tests targeting under-addressed markets. Their services support the management and prevention of heart disease through evidence-based science and clinical testing. They provide solutions-oriented services with integrity, aiming to be a premier cardiovascular testing provider.

Key facts about Cleveland HeartLab

Utilight develops a 'Pattern Transfer Printing' technology which is a non-contact 3D laser printing technology used in the PV metallization process of c-Si solar cells (for establishing a electrical contact between different solar cells). This manufacturing increasing solar cell efficiency and reduces PV manufacturing costs.

Key facts about Utilight

Shanghai Creation Investment's Investments by Stage

Shanghai Creation Investment has made 2 investments in Series A stage with an average round size of $2.9M and 2 investments in Series B stage with an average round size of $19.8M.
Here are Shanghai Creation Investment's investments by stage:
Stage of entry
No. of Investments
Series A
2
Series B
2
Breakdown of Shanghai Creation Investment's investments by stage of entrySeries A (2)Series B (2)
Note: We have considered here, only first round of investments

Shanghai Creation Investment's Investments by Sector

Shanghai Creation Investment has a diverse portfolio, with companies operating in the Life Sciences, Energy, Environment, Healthcare and High Tech. Notably, it has invested in 17 Enterprise (B2B) companies, 15 Tech companies, 8 Tech hardware companies and at least 4 companies focusing on Software.
Here are Shanghai Creation Investment's investments by sector:
Sector
No. of Investments
Life Sciences
2
Energy
1
Environment
1
Healthcare
1
High Tech
1
Breakdown of Shanghai Creation Investment's investments by sectorsLife Sciences (2)Energy (1)
Note: We have considered here, only first round of investments

Shanghai Creation Investment's Investments by Geography

Shanghai Creation Investment has made most investments in China (3), followed by Israel where it has made 1 investment.
Here are Shanghai Creation Investment's investments by geography:
Country
No. of Investments
China
3
Israel
1
Breakdown of Shanghai Creation Investment's investments by countriesChina (3)Israel (1)
Note: We have considered here, only first round of investments

Shanghai Creation Investment's recent investments

Shanghai Creation Investment has not made any investment in 2026 so far.
Here are the most recent investments by Shanghai Creation Investment:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jul 01, 2021
China
Series A
8355
Jan 18, 2021
China
Series B
4728
Nov 14, 2017
China
Series B
4542
Mar 07, 2016
Israel
Series A
2855

IPOs and Publicly Listed companies in Shanghai Creation Investment's Portfolio

4 of Shanghai Creation Investment's portfolio companies have become public. Akeso got listed on the Hong Kong Exchanges (HKG), in Apr 2020 at marketcap of $1.59B and Guangzhou Shangpin Home Furnishing got listed on the Shenzhen Stock Exchange (SZSE) at marketcap of $850M.
Here are Shanghai Creation Investment's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Apr 24, 2020
-
-
5163
Mar 07, 2017
-
-
5943
Jan 21, 2014
-
-
5052
-
Mar 07, 2016
Series A
2443

Acquired companies in Shanghai Creation Investment's Portfolio

1 company from Shanghai Creation Investment's portfolio has been acquired. The most recent acquisition was Cleveland HeartLab in Oct 2017 by Quest Diagnostics for $*****.
Here are Shanghai Creation Investment's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Oct 19, 2017
-
-
3408

Team profile of Shanghai Creation Investment

Shanghai Creation Investment has a team of 8 members including 2 Partners and 4 Principals located in China. Shanghai Creation Investment's team does not sit on the board of any company as of now.
Here is a list of all team members in Shanghai Creation Investment:
Name
Designation
Location
Board Memberships
Contact Details
Partner
China
-
Partner
Shanghai
-
-
Principal
Shanghai
-
-
Principal
Shanghai
-
-
Principal
Jing an
-
-
Principal
Chongqing
-

Co-investors of Shanghai Creation Investment

Over the past 10 years, 17 investors have co-invested in Shanghai Creation Investment's portfolio companies. This includes funds and angels.

Recent News related to Shanghai Creation Investment

•
Utilight Raises $2.9M |FinSMEsFinSMEs•Mar 09, 2016•Utilight, I2BF Global Ventures, Robert Bosch Venture Capital, Shanghai Creation Investment and 1 other
•
3D Printing Firm Utilight Raises $3M | News FlashNoCamels•Mar 08, 2016•Utilight, I2BF Global Ventures, Robert Bosch Venture Capital, Shanghai Creation Investment and 1 other
•
Venture Capital Access Online | Venture Capital NewsVCA Online•Oct 19, 2015•Surgical Theater, HTC Corporation, Shanghai Creation Investment
View all news related to Shanghai Creation Investment

FAQs about Shanghai Creation Investment

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford